Further to our letter dated 21st May, 2025 on the above subject, we would like to appraise you that the Board of Directors of the Company has approved in its Meeting the Audited Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors approved audited standalone and consolidated financial results for Q4 FY25 and the full financial year ended March 31, 2025. Standalone revenue from operations nearly doubled to ₹11,313.79 lakhs (vs ₹5,652.47 lakhs in FY24), while consolidated revenue grew about 43% to ₹20,114.87 lakhs (vs ₹14,046.40 lakhs). However, profitability weakened — standalone FY25 PAT was largely flat at ₹446.72 lakhs (vs ₹442.70 lakhs) and consolidated PAT fell to ₹351.41 lakhs (vs ₹413.30 lakhs), with PBT margins clearly compressed despite the strong top-line growth. Both standalone and consolidated Q4 results slipped into a small loss. The Board has decided not to declare any dividend and will retain the entire profit in reserves to fund expansion and growth. Statutory auditor M/s Jain Shrimal & Co. issued an unmodified (clean) audit opinion on both sets of results.
Strong revenue growth is positive, but sharp margin compression and a Q4 loss raise concerns about cost discipline and pricing power. The no-dividend decision signals reinvestment plans, which existing shareholders may view as growth-oriented but income-seeking investors may find unattractive.